Company Profile

Turning Concepts Into Products

JAKK Group develops and identifies new opportunities in medicine and health care. The challenge of medical technology development is to efficiently establish the value of a concept or product, prior to making significant investments in infrastructure and management teams. At JAKK Group, we meet this challenge by selecting the right opportunity for development and providing leadership, development expertise, resources, and business planning. We combine these development skills with appropriate fundraising through a broad range of contacts in venture capital, private equity, and corporate business development.

JAKK Group has established several venture backed companies. Together these companies have secured over $100 MM in venture capital financing from top tier firms. These pioneering companies have developed a broad range of medical products for stroke, heart attack, obesity, cardiac arrhythmia, gynecology, and aesthetic medicine. The companies include:

• CryoGen, Inc. (acquired by American Medical Systems)
• CryoCor, Inc. (spinout of CryoGen; NASDAQ:CRYO)
• INNERCOOL therapies, Inc. (acquired by Phillips Healthcares)
• Lithera, Inc.